Concepedia

Kiyotaka Nakano

KN

Statistics

Publications

8

Citations

769

H-Index

8

Active since

1987

Affiliations

Chugai Pharma (United States)(Current)

Jichi Medical University

The University of Tokyo

Kiyotaka Nakano is an author at Chugai Pharma (United States) specializing in immunology, medicine, and tumor biology.

ORCID

Top concepts

Publications per year

1987–2023

8

Publications

8

Identification of Soluble NH2-Terminal Fragment of Glypican-3 as a Serological Marker for Early-Stage Hepatocellular Carcinoma

Yoshitaka Hippo, Kiyotaka Watanabe, Akira Watanabe et al. · Cancer Research · 2004 · 294 citations · Full text

Anti–Glypican 3 Antibody as a Potential Antitumor Agent for Human Liver Cancer

Takahiro Ishiguro, Masamichi Sugimoto, Yasuko Kinoshita et al. · Cancer Research · 2008 · 176 citations

A long-acting anti–IL-8 antibody improves inflammation and fibrosis in endometriosis

Ayako Nishimoto, Izumi Sato, Kiyotaka Nakano et al. · Science Translational Medicine · 2023 · 94 citations

, , +18

A novel therapeutic approach for thrombocytopenia by minibody agonist of the thrombopoietin receptor

Tetsuro Orita, Hiroyuki Tsunoda, Naohiro Yabuta et al. · Blood · 2004 · 67 citations · Full text

Generation of a humanized anti-glypican 3 antibody by CDR grafting and stability optimization

Kiyotaka Nakano, Takahiro Ishiguro, Hiroko Konishi et al. · Anti-Cancer Drugs · 2010 · 63 citations

, , +22

1–5 of 8